Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.8 TWD -0.12%
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Net Income (Common) Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Net Income (Common)
NT$147.2m
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
48%
G
Grape King Bio Ltd
TWSE:1707
Net Income (Common)
NT$1.4B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
5%
Maywufa Co Ltd
TWSE:1731
Net Income (Common)
NT$173.2m
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
10%
Chlitina Holding Ltd
TWSE:4137
Net Income (Common)
NT$767.2m
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
0%

See Also

What is Maxigen Biotech Inc's Net Income (Common)?
Net Income (Common)
147.2m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Net Income (Common) amounts to 147.2m TWD.

What is Maxigen Biotech Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
48%

Over the last year, the Net Income (Common) growth was -23%. The average annual Net Income (Common) growth rates for Maxigen Biotech Inc have been 25% over the past three years , 20% over the past five years , and 48% over the past ten years .

Back to Top